FindTrial
Sign In

A study in which the indications for blood and blood components such as whole blood, PCV, platelets, FFPs in pregnant women and 6 weeks after delivery to the total number of Ante natal cases coming to BLDE hospital.

EVALUATION OF INDICATIONS FOR BLOOD COMPONENTS TRANSFUSION IN OBSTETRICS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/050742
Enrollment
300
Registered
2023-03-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

None listed

Sponsors

SHRI B M PATIL MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - All patients admitted to the obstetric unit requiring blood and blood products at Shri B.M. Patil Medical College and Hospital.

Exclusion criteria

Exclusion criteria: - Patients with history of Congenital hematological disorders (Thalassemias, Immune Thrombocytopenic Purpura, Sickle cell Anaemia). - Patients with history of Hematological malignancies

Design outcomes

Primary

MeasureTime frame
- To study the incidence and indications of blood and blood components in Obstetrics at a tertiary care center. - To study the various complications associated with the transfusion of blood products.Timepoint: 2 YEARS—

Secondary

MeasureTime frame
- To study the various complications associated with the transfusion of blood products.Timepoint: 2 YEARS—

Countries

India

Contacts

Public ContactMANCHINENI SOWMYA

SHRI B M PATIL MEDICAL COLLEGE AND HOSPITAL

Shailaja.bidri@bldedu.ac.in9880162550

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026